Winicker Norimed GmbH
Industry / private company
Location:
Nürnberg,
Germany (DE)
ISNI: 0000 0004 5910 1471
Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO study (2024)
Lüftner D, Schuetz F, Schneeweiss A, Hartkopf A, Bloch W, Decker T, Uleer C, et al.
Journal article
Sunitinib for Metastatic Renal Cell Carcinoma: Real-World Data from the STAR-TOR Registry and Detailed Literature Review (2024)
Uhlig A, Bergmann L, Bögemann M, Fischer T, Goebell P, Leitsmann M, Reichert M, et al.
Journal article
Axitinib beyond first-line therapy of Metastatic Renal Cell Carcinoma: Real World Data from the STAR-TOR registry (2023)
Uhlig A, Uhlig J, Woike M, Fischer T, Trojan L, Bergmann L, Bögemann M, et al.
Journal article